Keywords: first, approval, new, higher-dose, cerivastatin, 4mg, dose

First Approval Of New Higher-Dose Cerivastatin

Article | 05 November 1998

A new 0.4mg dose formulation of Bayer's HMG-CoA reductase inhibitorLipobay/Baycol (cerivastatin) has been approved in its first market, Mexico, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Baycol

Cerivastatin

Aspirin

Bayer

atorvastatin

Go to drug listing